Comparative efficacy of treatments for moderate-to-severe plaque psoriasis: An updated network meta-analysis (NMA)

被引:0
|
作者
Armstrong, April W. [1 ]
Soliman, Ahmed M. [2 ]
Puig, Lluis [3 ]
Betts, Keith A. [4 ]
Wang, Yan [4 ]
Gao, Yawen [4 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90007 USA
[2] AbbVie Inc, N Chicago, IL USA
[3] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Dermatol, Barcelona, Spain
[4] Anal Grp Inc, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
25030
引用
收藏
页码:AB4 / AB4
页数:1
相关论文
共 50 条
  • [1] A network meta-analysis of long-term efficacy and safety of treatments for moderate-to-severe plaque psoriasis
    Armstrong, A.
    Soliman, A.
    Betts, K.
    Wang, Y.
    Gao, Y.
    Stakias, V.
    Puig, L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E33 - E33
  • [2] Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    Armstrong, April W.
    Soliman, Ahmed M.
    Betts, Keith A.
    Wang, Yan
    Gao, Yawen
    Puig, Luis
    Augustin, Matthias
    [J]. DERMATOLOGY AND THERAPY, 2021, 11 (03) : 885 - 905
  • [3] Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    April W. Armstrong
    Ahmed M. Soliman
    Keith A. Betts
    Yan Wang
    Yawen Gao
    Luis Puig
    Matthias Augustin
    [J]. Dermatology and Therapy, 2021, 11 : 885 - 905
  • [4] COMPARATIVE EFFICACY OF BIMEKIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS: A NETWORK META-ANALYSIS
    Armstrong, A.
    Reich, K.
    Warren, R. B.
    Taieb, V
    Fahrbach, K.
    Kazmierska, P.
    Betts, M.
    Neupane, B.
    Kiri, S.
    Gordon, K.
    [J]. VALUE IN HEALTH, 2021, 24 : S14 - S14
  • [5] EFFICACY OF BRODALUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS: A NETWORK META-ANALYSIS
    Xue, W.
    Barbeau, M.
    Khoudigian-Sinani, S.
    Gray, E.
    Saharia, P.
    Frieder, D.
    [J]. VALUE IN HEALTH, 2018, 21 : S239 - S239
  • [6] Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple-treatments meta-analysis
    Xu, Shanshan
    Gao, Xing
    Deng, Jixiang
    Yang, Jiajia
    Pan, Faming
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 (01): : 47 - 56
  • [7] Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis
    April W. Armstrong
    Ahmed M. Soliman
    Keith A. Betts
    Yan Wang
    Yawen Gao
    Vassilis Stakias
    Luis Puig
    [J]. Dermatology and Therapy, 2022, 12 : 167 - 184
  • [8] Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Attia Attia
    Abdelrahman Ibrahim Abushouk
    Hussien Ahmed
    Mohamed Gadelkarim
    Ahmed Elgebaly
    Zeinab Hassan
    Mohamed M. Abdel-Daim
    Ahmed Negida
    [J]. Clinical Drug Investigation, 2017, 37 : 439 - 451
  • [9] Safety and Efficacy of Brodalumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Attia, Attia
    Abushouk, Abdelrahman Ibrahim
    Ahmed, Hussien
    Gadelkarim, Mohamed
    Elgebaly, Ahmed
    Hassan, Zeinab
    Abdel-Daim, Mohamed M.
    Negida, Ahmed
    [J]. CLINICAL DRUG INVESTIGATION, 2017, 37 (05) : 439 - 451
  • [10] The importance of assessing and adjusting for heterogeneity in network meta-analysis: A case study assessing the comparative efficacy of treatments for moderate-to-severe psoriasis
    Cameron, Chris
    Hutton, Brian
    Varu, Abhishek
    Druchok, Cheryl
    McElligott, Sean
    Schubert, Agata
    Situ, Aaron
    Villacorta, Reggie
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB288 - AB288